Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug;43(4):487-494.
doi: 10.4093/dmj.2019.0067. Epub 2019 Jul 17.

Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status

Affiliations

Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status

Bo Yeon Kim et al. Diabetes Metab J. 2019 Aug.

Abstract

Background: The objective of this study was to investigate the prevalence, management, and comorbidities of diabetes among Korean adults aged 30 years and older.

Methods: This study used 2013 to 2016 data from the Korea National Health and Nutrition Examination Survey, a nationally-representative survey of the Korean population. Diabetes was defined as fasting glucose ≥126 mg/dL, current use of antidiabetic medication, a previous history of diabetes, or glycosylated hemoglobin (HbA1c) ≥6.5%.

Results: In 2016, 14.4% (approximately 5.02 million) of Korean adults had diabetes. The prevalence of impaired fasting glucose was 25.3% (8.71 million). From 2013 to 2016, the awareness, control, and treatment rates for diabetes were 62.6%, 56.7%, and 25.1%, respectively. People with diabetes had the following comorbidities: obesity (50.4%), abdominal obesity (47.8%), hypertension (55.3%), and hypercholesterolemia (34.9%). The 25.1%, 68.4%, and 44.2% of people with diabetes achieved HbA1c <6.5%, blood pressure <140/85 mm Hg, and low density lipoprotein cholesterol <100 mg/dL. Only 8.4% of people with diabetes had good control of all three targets.

Conclusion: This study confirms that diabetes is as an important public health problem. Efforts should be made to increase awareness, detection, and comprehensive management of diabetes to reduce diabetes-related morbidity and mortality.

Keywords: Comorbidity; Diabetes mellitus; Hypercholesterolemia; Hypertension; Nutrition surveys; Obesity; Prevalence; Public health; Republic of Korea.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1. Estimated prevalence of adults (≥30 years old) with (A) diabetes and (B) impaired fasting glucose (household income: from the lowest to the highest quintiles [Q]).
Fig. 2
Fig. 2. Management of (A) diabetes and (B) type of treatment (awareness rate: rate of people diagnosed with diabetes by a doctor among people with diabetes [%]; treatment rate: rate of people treated with oral hypoglycemic agents, and/or insulin therapy among people with diabetes [%]; control rate: rate of people of glycosylated hemoglobin <6.5% among people with diabetes).
Fig. 3
Fig. 3. Glycemic control rate in diabetes. HbA1c, glycosylated hemoglobin.
Fig. 4
Fig. 4. Estimated prevalence of comorbidities in diabetes (obesity: body mass index [kg/m2] ≥25.0; abdominal obesity: men ≥90 cm, women ≥85 cm; hypertension: systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg and/or antihypertensive medications; hypercholesterolemia: total cholesterol ≥240 mg/dL and/or lipid-lowering medications).
Fig. 5
Fig. 5. Control rate of comorbidities and estimated proportion for health behaviors in diabetes (current smoking: smoked at least five packs of cigarettes [100 cigarettes] during lifetime; high-risk drinking: more than seven glasses in men or five glasses in women on the same occasion on each of 2 or more a week; regular walking exercise: 5 days or more per week and for 30 minutes or more per activity). HbA1c, glycosylated hemoglobin; BP, blood pressure; LDL-C, low density lipoprotein cholesterol; ABC, glycosylated hemoglobin, blood pressure, and low density lipoprotein cholesterol.

References

    1. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, Connolly V, King H. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005;28:2130–2135. - PubMed
    1. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44(Suppl 2):S14–S21. - PubMed
    1. Jeon JY, Ko SH, Kwon HS, Kim NH, Kim JH, Kim CS, Song KH, Won JC, Lim S, Choi SH, Jang MJ, Kim Y, Oh K, Kim DJ, Cha BY; Prevalence of diabetes and prediabetes according to fasting plasma glucose and HbA1c. Diabetes Metab J. 2013;37:349–357. - PMC - PubMed
    1. Jeon JY, Kim DJ, Ko SH, Kwon HS, Lim S, Choi SH, Kim CS, An JH, Kim NH, Won JC, Kim JH, Cha BY, Song KH Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Current status of glycemic control of patients with diabetes in Korea: the fifth Korea National Health and Nutrition Examination Survey. Diabetes Metab J. 2014;38:197–203. - PMC - PubMed
    1. Vital Statistics Division Statistics Korea. Shin HY, Lee JY, Kim JE, Lee S, Youn H, Kim H, Lee J, Park MS, Huh S. Cause-of-death statistics in 2016 in the Republic of Korea. J Korean Med Assoc. 2018;61:573–584.

Publication types

MeSH terms